Earnings results for Gamida Cell (NASDAQ:GMDA)
Gamida Cell Ltd. is expected* to report earnings on 11/10/2020 before market open. The report will be for the fiscal Quarter ending Sep 2020. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.29. The reported EPS for the same quarter last year was $-0.3.
Gamida Cell last posted its earnings data on August 11th, 2020. The reported ($0.37) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by $0.11. Gamida Cell has generated ($1.69) earnings per share over the last year. Gamida Cell has confirmed that its next quarterly earnings report will be published on Tuesday, November 10th, 2020.
Analyst Opinion on Gamida Cell (NASDAQ:GMDA)
6 Wall Street analysts have issued ratings and price targets for Gamida Cell in the last 12 months. Their average twelve-month price target is $16.40, predicting that the stock has a possible upside of 183.25%. The high price target for GMDA is $20.00 and the low price target for GMDA is $13.00. There are currently 6 buy ratings for the stock, resulting in a consensus rating of “Buy.”
Gamida Cell has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $16.40, Gamida Cell has a forecasted upside of 183.2% from its current price of $5.79. Gamida Cell has only been the subject of 3 research reports in the past 90 days.
Dividend Strength: Gamida Cell (NASDAQ:GMDA)
Gamida Cell does not currently pay a dividend. Gamida Cell does not have a long track record of dividend growth.
Insiders buying/selling: Gamida Cell (NASDAQ:GMDA)
In the past three months, Gamida Cell insiders have not sold or bought any company stock. 66.24% of the stock of Gamida Cell is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Earnings and Valuation of Gamida Cell (NASDAQ:GMDA
Earnings for Gamida Cell are expected to grow in the coming year, from ($1.29) to ($1.14) per share. The P/E ratio of Gamida Cell is -4.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Gamida Cell is -4.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Gamida Cell has a P/B Ratio of 4.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here